BackCelularity Overview

Celularity Current Cash

Track Celularity's current cash ($6.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$6.17M
↑ 736.72% YoYΔ $5.44M vs prior year quarter

Peer average

Loading

Celularity Current Cash History

Loading

Celularity vs. peers: Current Cash Comparison

Loading

Celularity Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Celularity (CELU) FAQ

Celularity (CELU) currently reports a current cash of $6.2M as of December 2025. That compares with $740K in the prior-year period — up 736.7% year over year. Use the charts on this page to explore Celularity's current cash history and peer comparisons.

Celularity's current cash increased from $740K to $6.2M — a 736.7% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Celularity reported $6.2M in current cash as of December 2025. That compares with $740K in the prior-year period — up 736.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $6.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Celularity, and consider following CELU for alerts when major investors trade the stock.

Celularity is classified in the Healthcare sector. On current cash, it currently shows $6.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CELU with unrelated industries.